- Cherishing the memory of Professor Sang-In Kim
-
Kwon SW
- KMID: 1782764
- Korean J Hematol.
- 2011 Jun;46(2):59-59.
- doi: 10.5045/kjh.2011.46.2.59
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- What should we consider in mixed chimerism after hematopoietic stem cell transplantation?
-
Lim J
- KMID: 1782781
- Korean J Hematol.
- 2011 Jun;46(2):143-144.
- doi: 10.5045/kjh.2011.46.2.143
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hope for better environments in overcoming and curing blood cancer
-
Lee CH
- KMID: 1782767
- Korean J Hematol.
- 2011 Jun;46(2):65-66.
- doi: 10.5045/kjh.2011.46.2.65
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The next step for Burkitt lymphoma
-
Cho B
- KMID: 1782765
- Korean J Hematol.
- 2011 Jun;46(2):60-61.
- doi: 10.5045/kjh.2011.46.2.60
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Practical applications of cytogenetic biodosimetry in radiological emergencies
-
Lee JK
- KMID: 1782766
- Korean J Hematol.
- 2011 Jun;46(2):62-64.
- doi: 10.5045/kjh.2011.46.2.62
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Gametocytes of Plasmodium falciparum in the megakaryocytes
-
Chandra H, Chandra S
- KMID: 1782769
- Korean J Hematol.
- 2011 Jun;46(2):68-68.
- doi: 10.5045/kjh.2011.46.2.68
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Bone marrow metastasis of small cell carcinoma of the lung mimicking Burkitt lymphoma/leukemias
-
Jung HR, Jeon DS, Park KU, Ha JS
- KMID: 1782768
- Korean J Hematol.
- 2011 Jun;46(2):67-67.
- doi: 10.5045/kjh.2011.46.2.67
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hemoglobin F level in different hemoglobin variants
-
Olufemi AE, Sola OB, Oluwaseyi , Ajani RA, Olusoji MO, Olubunmi H
- KMID: 1782776
- Korean J Hematol.
- 2011 Jun;46(2):118-122.
- doi: 10.5045/kjh.2011.46.2.118
BACKGROUND: Fetal hemoglobin (HbF) levels in different hemoglobin variants in Osogbo, Nigeria, were estimated using two principal methods of estimation using existing information for HbF concentration and distribution of various... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment with erythromycin for idiopathic thrombocytopenic purpura
-
Ohe M, Hashino S
- KMID: 1782780
- Korean J Hematol.
- 2011 Jun;46(2):139-142.
- doi: 10.5045/kjh.2011.46.2.139
Macrolides have both immunomodulatory and antibacterial effects. We report 3 cases of primary immune thrombocytopenia (ITP) patients who were successfully treated with macrolides, irrespective of Helicobacter pylori (H. pylori) infection... -
- CITED
-
- Close
- SHARE
-
- Close
- The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma
-
Min CK
- KMID: 1782771
- Korean J Hematol.
- 2011 Jun;46(2):80-87.
- doi: 10.5045/kjh.2011.46.2.80
Chronic graft-versus-host disease (CGVHD) is one of the most significant complications of long-term survivors after allogeneic hematopoietic stem cell transplantation (allo-HSCT). CGVHD may have protean manifestations and can pose unique... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection
-
Alavi S, Sharifi Z, Kord Valeshabad A, Nourbakhsh K, Shamsian B, Arzanian M, Safarisharari A, Navidinia
- KMID: 1782777
- Korean J Hematol.
- 2011 Jun;46(2):123-127.
- doi: 10.5045/kjh.2011.46.2.123
BACKGROUND: Although a marked proportion of thalassemic patients acquire Torque teno virus (TTV) through blood transfusion, its clinical importance is unclear. This study was designed to investigate the clinical importance... -
- CITED
-
- Close
- SHARE
-
- Close
- Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD
-
Shin OS, Harris JB
- KMID: 1782770
- Korean J Hematol.
- 2011 Jun;46(2):69-79.
- doi: 10.5045/kjh.2011.46.2.69
Graft-versus-host disease (GVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT) and this occurs as donor T lymphocytes, activated by recipient antigen presenting cells (APC), attack the host... -
- CITED
-
- Close
- SHARE
-
- Close
- Variant Burkitt-type translocation (8;22)(q24;q11) in plasma cell myeloma
-
Kim H, Moon HW, Hur M, Yun YM, Park CM, Lee MH
- KMID: 1782779
- Korean J Hematol.
- 2011 Jun;46(2):135-138.
- doi: 10.5045/kjh.2011.46.2.135
Variant Burkitt-type translocation, t(8;22)(q24;q11), is very rare in plasma cell myeloma. We report a 51-year-old male patient with plasma cell myeloma, who showed t(8;22) (q24;q11). He suffered from pelvic pain... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases
-
Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY
- KMID: 1782775
- Korean J Hematol.
- 2011 Jun;46(2):111-117.
- doi: 10.5045/kjh.2011.46.2.111
BACKGROUND: There has been no report on the clinical features or natural history of autoimmune hemolytic anemia (AIHA) in the Korean adult population. This study retrospectively analyzed the clinical characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse
-
Park SH, Chi HS, Min SK, Cho YU, Jang S, Park CJ, Lee JH, Lee JH, Lee KH, Im HJ, Seo JJ
- KMID: 1782772
- Korean J Hematol.
- 2011 Jun;46(2):88-95.
- doi: 10.5045/kjh.2011.46.2.88
BACKGROUND: Fms-like tyrosine kinase 3 internal tandem duplication (FLT3 ITD) mutation is related to poor prognosis in normal-karyotype acute myeloid leukemia (AML). However, the prognostic significance of the mutation at... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow
-
Yun GW, Yang YJ, Song IC, Baek SW, Lee KS, Lee HJ, Yun HJ, Kwon KC, Kim S, Jo DY
- KMID: 1782778
- Korean J Hematol.
- 2011 Jun;46(2):128-134.
- doi: 10.5045/kjh.2011.46.2.128
BACKGROUND: Hypocellularity of bone marrow (BM), not associated with significant dyshematopoiesis, is often found in patients with isolated thrombocytopenia, but its clinical implications have not been studied. We prospectively studied... -
- CITED
-
- Close
- SHARE
-
- Close
- Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
-
Jang G, Yoon DH, Kim S, Lee DH, Lee SW, Huh J, Suh C
- KMID: 1782774
- Korean J Hematol.
- 2011 Jun;46(2):103-110.
- doi: 10.5045/kjh.2011.46.2.103
BACKGROUND: The addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy (R-CHOP) has significantly improved clinical outcomes for patients with diffuse large B-cell lymphoma (DLBCL). However, new predictors... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution
-
Park ES, Kim H, Lee JW, Lim JY, Kang HJ, Park KD, Shin HY, Ahn HS
- KMID: 1782773
- Korean J Hematol.
- 2011 Jun;46(2):96-102.
- doi: 10.5045/kjh.2011.46.2.96
BACKGROUND: We compared the outcomes of patients with Burkitt lymphoma and French-American-British (FAB) L3 acute lymphoblastic leukemia treated using Lymphoma Malignancy B (LMB) or other treatment protocols. METHODS: Thirty-eight patients diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
